Cardiovascular comorbidities antedating the diagnosis of rheumatoid arthritis

被引:43
|
作者
Kerola, Anne M. [1 ,2 ,3 ]
Kerola, Tuomas [3 ]
Kauppi, Markku J. [2 ,4 ]
Kautiainen, Hannu [5 ]
Virta, Lauri J. [6 ]
Puolakka, Kari [7 ]
Nieminen, Tuomo V. M. [3 ,4 ,8 ]
机构
[1] Univ Helsinki, Sch Med, FI-00029 Helsinki, Finland
[2] Paijat Hame Cent Hosp, Div Rheumatol, Dept Internal Med, Lahti, Finland
[3] Paijat Hame Cent Hosp, Div Cardiol, Dept Internal Med, Lahti, Finland
[4] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland
[5] Kuopio Univ Hosp, Unit Primary Hlth Care, SF-70210 Kuopio, Finland
[6] Social Insurance Inst, Res Dept, Turku, Finland
[7] South Karelia Cent Hosp, Dept Med, Lappeenranta, Finland
[8] Univ Helsinki, Cent Hosp, Div Cardiol, FI-00029 Helsinki, Finland
关键词
Rheumatoid Arthritis; Cardiovascular Disease; Rheumatoid Factor; Epidemiology; POPULATION-BASED COHORT; CORONARY-HEART-DISEASE; RISK-FACTORS; MYOCARDIAL-INFARCTION; PROGNOSTIC-FACTORS; ONSET; MORTALITY; AGE; POLYMORPHISM; FINLAND;
D O I
10.1136/annrheumdis-2012-202398
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To assess the prevalence of coronary heart disease (CHD) and chronic hypertension among patients with rheumatoid arthritis (RA) at the time of diagnosis, in comparison with age-specific and sex-specific non-RA subjects. Furthermore, the impacts of age at the onset of RA, as well as gender and the presence of rheumatoid factor (RF) on the risk of these comorbidities, were evaluated. Methods A cohort of 7209 RA patients diagnosed between January 2004 and December 2007 was identified, based on a Finnish nationwide register on special reimbursements for medication costs. The presence of CHD and chronic hypertension antedating the diagnosis of RA was identified from the same register. The prevalence of the cardiovascular comorbidities was compared with the general Finnish population, and a standardised rate ratio (SRR) for both these cardiovascular diseases was calculated. Results The risk of having CHD at RA diagnosis was slightly elevated, the SRR being 1.10 (95% CI 1.01 to 1.20). Younger age at the onset of RA seemed to be related with higher SRR for CHD. In a subset analysis, an increased prevalence of hypertension (SRR 1.19, 95% CI 1.10 to 1.30) and CHD (SRR 1.15, 95% CI 1.00 to 1.32) was apparent only among the RF negative RA cases. Conclusions The SRR for CHD is augmented in RA patients already at disease onset, and more pronouncedly in early onset RA. The findings highlight the importance of early prevention of atherosclerosis, regardless of RF status.
引用
收藏
页码:1826 / 1829
页数:4
相关论文
共 50 条
  • [41] DXA and cardiovascular disease in rheumatoid arthritis: A scoping review
    Ebrahimiarjestan, Mina
    O'sullivan, Miriam
    Brennan, Attracta
    E, Erjiang
    Whelan, Bryan
    Yang, Lan
    Wang, Tingyan
    Silke, Carmel
    Yu, Ming
    Dempsey, Mary
    Carey, John J.
    JOURNAL OF CLINICAL DENSITOMETRY, 2025, 28 (02)
  • [42] Rheumatoid arthritis and cardiovascular disease: an update on treatment issues
    Barbhaiya, Medha
    Solomon, Daniel H.
    CURRENT OPINION IN RHEUMATOLOGY, 2013, 25 (03) : 317 - 324
  • [43] Rheumatoid Arthritis: Genetic Variants as Biomarkers of Cardiovascular Disease
    Rodriguez-Rodriguez, Luis
    Lopez-Mejias, Raquel
    Fernandez-Gutierrez, Benjamn
    Balsa, Alejandro
    Gonzalez-Gay, Miguel A.
    Martin, Javier
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (02) : 182 - 201
  • [44] Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis
    Yu, Kuang-Hui
    Chen, Hsin-Hua
    Cheng, Tien-Tsai
    Jan, Yeong-Jian
    Weng, Meng-Yu
    Lin, Yeong-Jang
    Chen, Hung-An
    Cheng, Jui-Tseng
    Huang, Kuang-Yung
    Li, Ko-Jen
    Su, Yu-Jih
    Leong, Pui-Ying
    Tsai, Wen-Chan
    Lan, Joung-Liang
    Chen, Der-Yuan
    MEDICINE, 2022, 101 (01) : E28501
  • [45] Comorbidities As Risk Factors for Rheumatoid Arthritis and Their Accrual After Diagnosis
    Kronzer, Vanessa L.
    Crowson, Cynthia S.
    Sparks, Jeffrey A.
    Myasoedova, Elena
    Davis, John M., III
    MAYO CLINIC PROCEEDINGS, 2019, 94 (12) : 2488 - 2498
  • [46] The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients
    Arts, Elke E. A.
    Fransen, Jaap
    den Broeder, Alfons A.
    Popa, Calin D.
    van Riel, Piet L. C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 998 - 1003
  • [47] Cardiovascular disease in patients with rheumatoid arthritis
    Liao, Katherine P.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2017, 27 (02) : 136 - 140
  • [48] Cardiovascular risk in patients with rheumatoid arthritis
    Lauper, Kim
    Gabay, Cem
    SEMINARS IN IMMUNOPATHOLOGY, 2017, 39 (04) : 447 - 459
  • [49] Comparison of the risks of hospitalisation for cardiovascular events in patients with rheumatoid arthritis treated with tocilizumab and etanercept
    Generali, E.
    Carrara, G.
    Selmi, C.
    Verstappen, S.
    Zambon, A.
    Bortoluzzi, A.
    Silvagni, H.
    Scire, C. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (02) : 310 - 313
  • [50] CARDIOVASCULAR RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Nikitina, N. M.
    Rebrov, A. P.
    TERAPEVTICHESKII ARKHIV, 2009, 81 (06) : 29 - 34